登录 注册 会员服务 联系我们

Far Beyond Cancer Immunotherapy: Reversion of Multi-Malignant Phenotypes of Immunotherapeutic-Resistant Cancer by Targeting the NANOG Signaling Axis

  • Published:2020 Issue:1 Volume:20 Page:
  • ISSN:1598-2629
  • Container-title:Immune Network
  • language:en
  • Short-container-title:Immune Netw

Author:

Oh Se Jin123ORCID,Lee Jaeyoon4ORCID,Kim Yukang5,Song Kwon-Ho123ORCID,Cho Eunho123ORCID,Kim Minsung5,Jung Heejae5,Kim Tae Woo123ORCID

Affiliation:

1. Department of Biochemistry & Molecular Biology, Korea University College of Medicine, Seoul 02841, Korea.

2. Department of Biomedical Science, Korea University College of Medicine, Seoul 02841, Korea.

3. Translational Research Institute for Incurable Diseases, Korea University College of Medicine, Seoul 02841, Korea.

4. College of Science, College of Social Sciences and Humanities, Northeastern University, Boston, MA 02115, USA.

5. Korea University College of Medicine, Seoul 02841, Korea.

Funder

National Research Foundation of Korea

Publisher

The Korean Association of Immunobiologists

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3